Current estimates for research and development of new medicines range from €40m to €3.9bn. The extortionate cost of trials is used to justify high prices of new medicines, but companies do not publish either the topline or a breakdown of their spending…
Friday, April 26, 2024
Cost of developing new drugs may be far lower than industry claims, trial reveals
Médecins Sans Frontières (MSF) is challenging drug companies to be transparent about the cost of trials, which has always been shrouded in secrecy. Its own bill for landmark trials of a four-drug combination treatment for drug-resistant tuberculosis came to €34m (£29m).
Subscribe to:
Post Comments (Atom)
Click Older Posts above to see more.
No comments:
Post a Comment